BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Hoeve K, Seyed Tabib NS, Dreesen E, Tops S, Hoffman I, Gils A, Ferrante M, Vermeire S. Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy. J Pediatr 2022;240:150-157.e4. [PMID: 34481805 DOI: 10.1016/j.jpeds.2021.08.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang MY, Zhao JW, Zheng CQ, Sang LX. Therapeutic drug monitoring in inflammatory bowel disease treatments. World J Gastroenterol 2022; 28(15): 1604-1607 [DOI: 10.3748/wjg.v28.i15.1604] [Reference Citation Analysis]
2 Rakowsky S, Cheifetz AS, Papamichael K. Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD? Aliment Pharmacol Ther 2022;55:1049-50. [PMID: 35362141 DOI: 10.1111/apt.16889] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]